An interventional study of Relationship-use questionnaire in Borderline Personality Disorder, Borderline Personality Disorder (BPD) and Bipolar Disorder (BD), sponsored by University Hospital, Montpellier. Recruiting at 1 site in France. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-22.
Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Borderline Personality Disorder with a site in France — 12 open to participants now, 13 under way, none of them phase 3. Borderline Personality Disorder · France.
Among the 32 studies in Borderline Personality Disorder with a site in France, this one is the 6th largest by planned enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2026, is one of 20 with no phase, reaches primary completion later than 8 of the 12 other live ones, and was the 29th registered.
279 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.
Browse Borderline Personality Disorder studies →12 of the 32 studies in Borderline Personality Disorder with a site in France are open now. Recruiting first, the newest first:
University Hospital, Strasbourg, France · Sites in France
Ages 12–18
University Hospital, Strasbourg, France · Sites in France
Ages 18–60 · Healthy volunteers
AddiPsy · Sites in France
Ages 18+
Etablissement Public de la Sante Mentale de la Somme · Sites in France
Ages 12–17 · Women only · Healthy volunteers
Hôpital le Vinatier · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 49 Borderline Personality Disorder studies recruiting now, 18 (37%) set no upper age limit and 30 (61%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 194 is above the median of 70 across 222 interventional studies indexed under Borderline Personality Disorder.
Median enrollment 72 across the 24 interventional studies, 99 across the 8 observational. Of the 13 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 32 have an industry lead sponsor. The 10 most frequent:
University Hospital, Montpellier is the lead sponsor of 1,264 studies on the registry; 226 are open to participants now.
University Hospital, Montpellier has 8 studies filed under Borderline Personality Disorder — fewer than ten, so there is no comparison to draw.
2 of the studies in Borderline Personality Disorder with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07540429Etablissement Public de la Sante Mentale de la SommeADOLESCENTS IMAGING USING fMRI: Feasibility Study | 2027-06-08 |
| NCT07794332University Hospital, Strasbourg, FranceSymptom Assessment in Adolescents Placed on Child Welfare | 2027-09-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Borderline Personality Disorder with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to explore a novel conceptualization of Borderline Personality Disorder (BPD) as a "Relationship Use Disorder." The research proposes that BPD shares key features with behavioral addictions, specifically addiction to interpersonal relationships. The study builds upon previous findings suggesting that individuals with BPD experience intense emotional dysregulation, including negative self-perception, shame, and a compulsive need for external validation. This addiction to relationships, much like substance use disorders, is thought to contribute significantly to the difficulties faced by these individuals, including interpersonal conflicts, self-destructive behaviors, and emotional instability.
The study seeks to demonstrate that the relational difficulties central to BPD meet the diagnostic criteria for addiction as defined by the DSM-5. It will also explore how these relational struggles are mediated by dysfunctional self-perception and whether they are linked to behaviors such as compulsive sexual behaviors (CSBD) or suicidal tendencies. Additionally, the research will investigate the relationship between addiction to relationships and neurobiological factors, including endorphin levels, in individuals with BPD compared to those with bipolar disorder and healthy controls. The hypothesis is that individuals with BPD will exhibit higher levels of relationship addiction, with this addiction being tied to their perception of self-worth and emotional experiences in relationships.
This innovative approach aims to refine the understanding of BPD, reduce stigma, and improve treatment strategies by providing scientific evidence supporting the conceptualization of BPD as a "Relationship Use Disorder."
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with borderline personality disorder without bipolar disorder
Other: Relationship-use questionnaire
patients with bipolar disorder without borderline personality disorder
Other: Relationship-use questionnaire
Healthy controls (i.e. without psychiatric disorders), from the general population
Other: Relationship-use questionnaire
Questionnaire adapted from the 'Substance Use Disorders' section of the DSM-5: Disorder related to the use of close relationships
Relational Addiction
Using the experimental relationship-use questionnaire based on the DSM-5 Substance Use Disorder items among patients with Borderline Personality Disorder (BPD) without Bipolar Disorder (BD), those with BD without BPD, and healthy controls.
Time frame: Measured at baseline
Function Acquisition Speed Test (FAST)
Administer the Function Acquisition Speed Test (FAST) to measure how quickly individuals learn associations between stimuli and responses, focusing on emotional biases related to self (e.g., feelings of unworthiness, ridicule) and others (e.g., dependency, validation). The aim is to assess the intensity of emotional biases in BPD patients compared to BD patients and healthy controls.
Time frame: Measured at baseline
Visual Analogue Scale (VAS) for Perceived Alignment with BPD
After viewing an educational video explaining Borderline Personality Disorder (BPD) as relational addiction, assess how participants perceive the alignment of their personal experiences with BPD traits, using a Visual Analogue Scale (VAS) ranging from 0 to 10.
Time frame: Measured at baseline
Love Addiction Inventory (LAI)
Using the Love Addiction Inventory (LAI), a 24-item self-report scale, to measure symptoms of love addiction. Participants rate their responses on a 5-point Likert scale, with higher scores indicating greater levels of love addiction symptoms, among patients with Borderline Personality Disorder (BPD) without Bipolar Disorder (BD), those with BD without BPD.
Time frame: Measured at baseline
Beta-Endorphin Levels
valuate the correlation between beta-endorphin levels and the dimension of relational addiction among patients with BPD, BD, and healthy controls
Time frame: Measured at baseline
Dysfunctional Self-Perception and Related Indicators (SES)
Assessing dysfunctional self-perception and its associated indicators-including feelings of emptiness - among BPD group, BD group and HC group, using : * Subjective Emptiness Scale (SES): An 8-item self-report scale measuring feelings of inner emptiness. Higher scores indicate greater perceived emptiness.
Time frame: Measured at baseline
Dysfunctional Self-Perception and Related Indicators (RSES)
Assessing dysfunctional self-perception and its associated indicators-including self-esteem-among BPD group, BD group and HC group, using : \- Rosenberg Self-Esteem Scale (RSES): A 10-item self-report scale assessing global self-worth. The total score ranges from 0 to 30, with higher scores indicating higher self-esteem.
Time frame: Measured at baseline
Dysfunctional Self-Perception and Related Indicators (ESS)
Assessing dysfunctional self-perception and its associated indicators-including shame,-among BPD group, BD group and HC group, using : \- Experience of Shame Scale (ESS): A 25-item self-report scale covering eight domains of shame experiences, including personal habits, interpersonal behaviors, and body image. Higher scores reflect greater shame experiences.
Time frame: Measured at baseline
Dysfunctional Self-Perception and Related Indicators (VAS)
Assessing dysfunctional self-perception and its associated indicators-including shame,-among BPD group, BD group and HC group, using : \- Visual Analog Scale (VAS) for Psychological Pain: Participants mark a point on a 10 cm line that represents their current level of psychological pain. Higher values indicating greater psychological pain.
Time frame: Measured at baseline
Painful Experiences Related to the Relational Object (MSR)
Assessing the impact of painful relational experiences, focusing on rejection sensitivity, among patients diagnosed with Borderline Personality Disorder (BPD) without Bipolar Disorder (BD), those with BD without BPD, and healthy controls (HC), using : \- Rejection Sensitivity Scale (MSR): A 9-item self-report scale assessing the level of anxiety and likelihood of perceiving rejection in various interpersonal situations. Higher scores indicate greater sensitivity to rejection.
Time frame: Measured at baseline
Painful Experiences Related to the Relational Object (ESUL)
Assessing the impact of painful relational experiences, focusing on loneliness, among patients diagnosed with Borderline Personality Disorder (BPD) without Bipolar Disorder (BD), those with BD without BPD, and healthy controls (HC), using : \- University of Laval Loneliness Scale (ESUL): A 20-item self-report scale measuring perceived loneliness in adults. The scale assesses both emotional and social loneliness. Higher scores indicate greater loneliness.
Time frame: Measured at baseline
Painful Experiences Related to the Relational Object (RSQ)
Assessing the impact of painful relational experiences, focusing on attachment styles, among patients diagnosed with Borderline Personality Disorder (BPD) without Bipolar Disorder (BD), those with BD without BPD, and healthy controls (HC), using : \- Relationship Scale Questionnaire (RSQ): A 30-item self-report scale evaluating attachment styles and relational anxiety. Higher scores reflect more insecure attachment styles.
Time frame: Measured at baseline
Compulsive Sexual Behavior Disorder
Assessing the severity of compulsive sexual behaviors (CSBD) among patients with Borderline Personality Disorder (BPD) without Bipolar Disorder (BD), those with BD without BPD, and healthy controls (HC), using : \- Compulsive Sexual Behavior Scale (CSBD-19): a 19-item self-report scale that assesses the severity of compulsive sexual behaviors, following the diagnostic guidelines of the ICD-11. The scale evaluates key dimensions of CSBD, including control, salience, relapse, dissatisfaction, and negative consequences. Participants rate the frequency and impact of their sexual behaviors and impulses on a 5-point Likert scale. Higher scores indicate more severe compulsive sexual behavior.
Time frame: Measured at baseline
Non-Relational Addictive Propensity
Assessment of Non-Relational Addictive Behaviors in Patients with Borderline Personality Disorder (BPD), Bipolar Disorder (BD), and Healthy Controls (HC), using substance use disorder criteria. Participants will be screened for a range of substances (e.g., alcohol, opioids, stimulants) and will be asked about the frequency, quantity, and impact of substance use in their life.
Time frame: Measured at baseline
Suicidal Tendencies
Assessment of Suicidal Tendencies in Patients with Borderline Personality Disorder (BPD), Bipolar Disorder (BD), and Healthy Controls (HC), using : * Columbia-Suicide Severity Rating Scale (C-SSRS): The C-SSRS is a clinician-administered assessment tool designed to measure the severity and frequency of suicidal and para-suicidal behaviors. The scale includes questions about lifetime suicidal ideation, recent suicidal ideation, and behaviors, including planning, attempts, and self-injurious actions.
Time frame: Measured at baseline
Started Jun 2026 (actual). Primary completion is estimated for Apr 2028, 22 months after the start.
Of 106 non-industry interventional studies with no phase under Borderline Personality Disorder, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 54. This study's planned 22 months is below that.
Counting every sponsor, half of 108 studies reached it within 35 months; a quarter within 24 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Borderline Personality Disorder →
University Hospital, Montpellier →